More Presentations from Dr.Naina Mohamed Pakkir Maideen
§ On 20th Nov 2014, the Food and Drug Administration (FDA) is advising consumers not to purchase or use “Feng Shi Ling”.
§ “Feng Shi Ling” is promoted and sold as an herbal medication for arthritic pain associated with rheumatoid arthritis and osteoporosis.
§ FDA laboratory analysis found that “Feng Shi Ling” contains the undeclared NSAIDs (Diclofenac and Indomethacin).
§ Due to the presence of NSAIDs, “Feng Shi Ling” may increase the risk of …
· Myocardial infarction
· Stroke
· Gastro Intestinal Hemorrhage
· Gastro Intestinal perforation
· Bronchoconstriction
· Rhinosinusitis
· Acute urticaria
· Angioedema (skin, lips, and mouth)
· Allergic reactions (Urticaria, Angioedema or Anaphylaxis)
· Bleeding
· Early closure of Ductus arteriosus
· Renal ischemia (In patients with CHF, CKD, etc)
· Edema and Hypertensive complications
§ These hidden drug ingredients may interact with other medications such as …
· Warfarin, Apixaban, Rivaroxaban, Enoxaparin, Dalteparin, Aredeparin, Tinazaparin, Ibritumomab, Tositumomab, Cabozantinib, Ponatinib, Regoratinib, Prasugrel, Anisindione, Fondaparinux or Desirudin
· Leflunomide, Teriflunomide or Lomitapide
· Adefovir, Cidofovir, Tenofovir, Tacrolimus, Sirolimus, Sodium Biphosphate or IV Immunoglobulins
· ACE inhibitors
· Corticosteroids or SSRIs
§ Consumers should stop using this product immediately and throw it away.
§ Consumers should consult a health care professional as soon as possible if they have experienced any negative side effects, such as unusually dark stools or urine, stomach pain, increased bruising, and other signs of bleeding.
